1. Show article details.

    BRIEF-Resmed Inc. Announces Results For The Fourth Quarter Of Fiscal Year 2020

    Reuters – 5:12 PM ET 08/05/2020

    Resmed Inc (RMD): * . ANNOUNCES RESULTS FOR THE FOURTH QUARTER OF FISCAL YEAR 2020. * Q4 NON-GAAP EARNINGS PER SHARE $1.33. * Q4 GAAP EARNINGS PER SHARE $1.22. * Q4 EARNINGS PER SHARE ESTIMATE $1.08 -- REFINITIV IBES DATA. * QTRLY REVENUE INCREASED 9% TO $770.3 MILLION; UP 10% ON A CONSTANT CURRENCY BASIS Source text for Eikon: Further company coverage:

  2. Show article details.

    ResMed Inc. Announces Results for the Fourth Quarter of Fiscal Year 2020

    Business Wire – 4:05 PM ET 08/05/2020

    - Year-over-year revenue grows 9%, non-GAAP operating profit up 24% Note: A webcast of ResMed’s conference call will be available at 4:30 p.m. ET today at http://investor.resmed.com SAN DIEGO---- ResMed Inc. (RMD), a world-leading digital health company, today announced results for its quarter ended June 30, 2020.

  3. Show article details.

    ResMed to Report Fourth Quarter Fiscal 2020 Earnings on August 5, 2020

    Business Wire – 4:30 PM ET 07/15/2020

    ResMed (RMD) today announced it plans to release financial and operational results for the fourth quarter of fiscal year 2020 on Wednesday, August 5, 2020, after the New York Stock Exchange closes. Earnings webcast details: Please note that ResMed (RMD) does not use outside phone lines to access the earnings call.

  4. Show article details.

    Crowded trade, high valuations: why investors worry about tech stocks

    Reuters – 11:48 AM ET 07/14/2020

    Some investors are getting increasingly worried about the outlook for technology and big growth stocks after a massive rally which has pushed the Nasdaq Composite index to record highs despite the coronavirus-inflicted economic damage.

  5. Show article details.

    Crowded trade, high valuations: why investors worry about tech stocks

    Reuters – 11:45 AM ET 07/14/2020

    Some investors are getting increasingly worried about the outlook for technology and big growth stocks after a massive rally which has pushed the Nasdaq Composite index to record highs despite the coronavirus-inflicted economic damage.

  6. Show article details.

    Propeller Health Sensor to Be Co-Packaged With Recently Approved Enerzair® Breezhaler® Asthma Medication in Europe

    Business Wire – 1:30 AM ET 07/07/2020

    Enerzair® Breezhaler® plus sensor is the first asthma medication to be co-packaged and co-prescribed with a digital health platform Propeller Health today announced a collaboration with Novartis to co-package the Propeller digital health platform with Enerzair® Breezhaler®, a recently approved Novartis medication developed to treat uncontrolled asthma. This press release features multimedia.

  7. Show article details.

    Sommetrics Requests Emergency Use Authorization to Introduce Its aerSleep Product for Sleep Apnea Patients at Risk of COVID-19

    Business Wire – 9:00 AM ET 06/23/2020

    Sommetrics, Inc., a company providing products and services to improve sleep quality, announced it filed an application with the FDA for Emergency Use Authorization to introduce its aerSleep® II product to treat obstructive sleep apnea in people at risk of COVID-19.

  8. Show article details.

    Medtronic ties up with Foxconn to boost ventilator production

    Reuters – 9:09 AM ET 06/18/2020

    Medtronic (MDT) said on Thursday it had partnered with Foxconn to boost production of its ventilators to 10,000 over the next year amid surging demand as the respiratory disease caused by the new coronavirus overwhelms hospitals.

  9. Show article details.

    Sophisticated Medical Devices Allow for Improved Patient Monitoring

    PR Newswire – 9:00 AM ET 06/09/2020

    NEW YORK, June 9, 2020 Medical devices range from simple tongue depressors and bedpans to complex programmable pacemakers and closed loop artificial pancreas systems. In recent years, werable devices have also become part of the industry.

  10. Show article details.

    ResMed Announces Participation in the William Blair 40th Annual Growth Stock Conference

    Business Wire – 9:00 AM ET 06/03/2020

    ResMed (RMD) today announced Mick Farrell, chief executive officer, will participate in a virtual fireside chat at the William Blair 40th Annual Growth Stock Conference on Wednesday, June 10, 2020, beginning at approximately 12:00 p.m. via video webcast.

  11. Show article details.

    Rugby League Legend Brad Fittler Teams Up with ResMed to Help Australians Sleep Better

    Business Wire – 10:10 PM ET 05/27/2020

    “Freddy” Aims to Change Up the Play on Sleep ResMed (RMD) today announced it has teamed up with Rugby League Hall of Fame inductee, current NSW Blues State of Origin head coach, and Channel 9 commentator Brad Fittler to help raise awareness of the importance of healthy sleep. This press release features multimedia.

  12. Show article details.

    BRIEF-Propeller Health Receives FDA Clearance To Connect Patients Using The Symbicort® Inhaler To Its Digital Health Platform

    Reuters – 8:32 AM ET 05/26/2020

    Resmed Inc (RMD): * PROPELLER HEALTH RECEIVES FDA CLEARANCE TO CONNECT PATIENTS USING THE SYMBICORT® INHALER TO ITS DIGITAL HEALTH PLATFORM Source text for Eikon: Further company coverage:

  13. Show article details.

    Propeller Health Receives FDA Clearance to Connect Patients Using the Symbicort® Inhaler to its Digital Health Platform

    Business Wire – 8:00 AM ET 05/26/2020

    The sensor, part of the 510 clearance, was developed in partnership with AstraZeneca Propeller Health, a leading digital health company dedicated to the management of asthma and COPD, today announced it has received 510 clearance from the U.S. Food and Drug Administration to connect patients using the Symbicort Inhaler to its digital health platform. This press release features multimedia.

  14. Show article details.

    MatrixCare Celebrates Post-acute Healthcare Workers with National Heroes Program

    Business Wire – 9:00 AM ET 05/20/2020

    More than 140 long-term care facility and home-based care employees recognized for commitment to keeping patients and residents safe and well during the COVID-19 pandemic MatrixCare is pleased to honor post-acute healthcare workers as part of the company’s “Nominate a Hero” program, an initiative launched last month to honor the committed employees working for out-of-hospital care facilities an...

  15. Show article details.

    ResMed Debuts MaskSelector, a Digital Tool for Remote CPAP Mask Fittings

    Business Wire – 9:00 AM ET 05/18/2020

    55% of HME respondents say mask selection is the biggest challenge during remote CPAP setups in a recent survey ResMed (RMD) has launched ResMed MaskSelector, a digital tool to make remote patient mask selection and sizing easier and more effective, helping patients receive the care they need from home. This press release features multimedia.

Page:

Today's and Upcoming Events

  • Oct
    22

    RMD to announce Q1 earnings (Unconfirmed)

  • Aug
    19

    RMD ex-Dividend for $0.39 on 08/19/2020

    • Announce Date: 08/05/2020
    • Record Date: 08/20/2020
    • Pay Date: 09/24/2020

Past Events (last 90 days)

  • Aug
    05

    RMD announced Q4 earnings.

  • May
    13

    RMD ex-Dividend for $0.39 on 05/13/2020

    • Announce Date: 04/30/2020
    • Record Date: 05/14/2020
    • Pay Date: 06/18/2020
Data provided by Thomson Reuters © 2020

Technical Events

Technical Analysis

PROVIDED BY TRADING CENTRAL
As with all your investments through Fidelity, you must make your own determination whether an investment is appropriate for you. Fidelity is not recommending or endorsing this security by making it available to customers. You should conduct research and perform a thorough investigation as to the characteristics of any securities you intend to purchase. Before investing, you should read the prospectus, offering circular, indenture, or similar document carefully for a full description of the product, including its features and risks, to determine whether it is an appropriate investment for your investment objectives, risk tolerance, financial situation and other individual factors, and be sure to re-evaluate those factors on a periodic basis.

Performance data shown represents past performance, which is no guarantee of future results. Current performance may be higher or lower than the performance data quoted. Yield and return will vary, therefore, you may have a gain or loss when you sell your shares.


Stock markets are volatile and can decline significantly in response to adverse issuer, political, regulatory, market, or economic developments. Growth stocks can be more volatile than other types of stocks. Value stocks can continue to be undervalued by the market for long periods of time. Foreign securities are subject to interest-rate, currency-exchange-rate, economic, and political risks, all of which are magnified in emerging markets. Illiquidity is an inherent risk associated with investing in real estate and REITs. There is no guarantee the issuer of a REIT will maintain the secondary market for its shares and redemptions may be at a price which is more or less than the original price paid. Closed-end funds can trade at a discount to their NAV. Shareholders of Master Limited Partnerships may be treated as partners for tax purposes. Partnerships issue a Schedule K-1 (Form 1065) rather than a Form 1099 form for tax purposes. It lists the partner's share of income, deductions, credits, etc. Speak with your tax advisor to determine how this may affect you. A royalty trust is a type of corporation, mostly in the United States or Canada, usually involved in oil and gas production or mining. Royalty trusts may have special tax treatment, so you should consult a tax advisor on the potential tax consequences of investing in them.

News, commentary and events are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.

Any data, charts and other information provided on this page are intended for research purposes to help self-directed investors evaluate many types of securities including, but not limited to common stocks, American Depository Receipts, Master Limited Partnerships, real estate investment trusts. traditional preferred stock, trust preferred securities, third-party trust certificates, convertible securities, mandatory convertible securities and other exchange-traded equity and/or debt securities. Criteria and inputs entered, including the choice to make security comparisons, are at the sole discretion of the user and are solely for the convenience of the user. Analyst opinions, ratings and reports are provided by third-parties unaffiliated with Fidelity. All information supplied or obtained from this page is for informational purposes only and should not be considered investment advice or guidance, an offer of or a solicitation of an offer to buy or sell a security, or a recommendation or endorsement by Fidelity of any security or investment strategy. Fidelity does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from its use.

462499.6.0
See the Latest Features
Personalized
Get relevant information about your holdings right when you need it.
See Your Performance Click the portfolio icon to get information about stocks you own without leaving the research page.
Faster Access to Positions A shortcut to view the full list of positions in your portfolio? Yes, please! Use the ticker search box.
Add Your Own Notes Use Notebook to save your investment ideas in one convenient, private, and secure place.
Convenient For You
Research that's clear, accessible, and all in one place makes for a better experience.
One-Stop Shop See everything you need to make investment decisions right in the dashboard.
Access Anywhere No matter where you are, use the Stock Research experience across multiple devices.
New Ideas, On the Ready Find new ideas using quick links to the Stock Screener.
New Ways to Research
Discover new tools to add or diversify your existing research strategy.
StockTwits Read live tweets from the financial and investing community about the stock you're interested in.
Fundamental Analysis Save time on research by getting an overall assessment of a company's valuation, quality, growth stability, and financial health.
Recognia Technical Analysis Perfect for the technical trader—this indicator captures a stock's technical events and converts them into short, medium, and long-term sentiment.
Top Competitors See how a stock measures up by instantly comparing it to the industry average and its top four competitors.
Social Sentiment Get a sense of people's overall feelings towards a company in social media with this summary tool.
Earnings Data Monitor earnings expectations over the past three quarters and model a stock's price based on its P/E.